Skip to main content
RGEN logo

RGEN · Repligen Corp

Track RGEN — free
$166.83 -0.66 (-0.39%) At close · Aug 14
Market Cap
$9.42B
Shares
56.44M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-07-16 Garland Jason K 530
2026-06-25 Garland Jason K 733
2026-04-21 Loeillot Olivier 3,832
2025-12-17 DAWES KAREN A 275
2025-11-25 Loeillot Olivier 7,041
2025-11-18 Bylund James 2,191
2025-11-13 Hunt Anthony 20,000
2025-11-12 Hunt Anthony 25,000
2025-09-10 Hunt Anthony 29,111
2025-05-15 Hunt Anthony 26,447
2025-03-17 Hunt Anthony 26,756
2024-11-21 Anthony Hunt 24,246
2024-09-10 Hunt Anthony 22,191
2024-08-02 Ralf Kuriyel 7,148
2024-08-01 Christine Gebski 2,160
2024-08-01 Ralf Kuriyel 4,465
2024-05-21 Hunt Anthony 20,072
2024-03-11 Ralf Kuriyel 3,517
2024-03-08 Hunt Anthony 16,707
2024-02-27 Karen Dawes 1,000
2024-02-23 James Bylund 4,373
2023-11-13 Christine Gebsky 3,788
2023-08-29 Karen Dawes 850
Showing 1–23 of 23 filings
Key facts CIK 730272 CUSIP 759916109 13F (30d) 461 filings 436 filers Visit website Investor relations